immunology of infectious and parasitic diseases - XXXVII Congress ...
immunology of infectious and parasitic diseases - XXXVII Congress ...
immunology of infectious and parasitic diseases - XXXVII Congress ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
CRITICAL ROLE OF IL-6 IN REGULATORY T CELLS DETERMINES THE<br />
OUTCOME OF GUT INFLAMMATION DURING TOXOPLASMA GONDII<br />
INFECTION<br />
MURILO SOLANO-DIAS(1), LUCIANA BENEVIDES(1), MARIA C. SOUZA(1),<br />
GIULIANO BONFÁ(1), RODRIGO R. RODRIGUES(1), BRUNA B. CHAHUD(1),<br />
TIAGO W. P. MINEO(3), ALEXANDRE S. BASSO(2), DENISE M.<br />
FONSECA(1), JOÃO S. SILVA(1)<br />
(1) Department <strong>of</strong> Biochemistry <strong>and</strong> Immunology - Ribeirão Preto Medical<br />
School - University <strong>of</strong> São Paulo - Ribeirão Preto, Brazil; (2) Department <strong>of</strong><br />
Microbiology, Immunology <strong>and</strong> Parasitology, Federal University <strong>of</strong> São Paulo-<br />
São Paulo – Brazil; (3) Institute <strong>of</strong> Biomedical Sciences - Federal University <strong>of</strong><br />
Uberlândia - Uberlândia – Brazil<br />
Introduction: Recent findings point out for the role <strong>of</strong> regulatory T cells (Treg)<br />
in the protection against inflammatory <strong>diseases</strong> induced by parasite infections.<br />
The oral infection with Toxoplasma gondii leads to an intense inflammation in<br />
the gut <strong>of</strong> susceptible C57BL/6 mice, which succumb to the infection due the<br />
reduction <strong>of</strong> Treg frequency <strong>and</strong> suppressive function. Even though the Th1<br />
related cytokines have been associated to this event, it has been reported that<br />
pro-inflammatory cytokines, such as IL-6, might induce the conversion <strong>of</strong> natural<br />
Tregs in Th17 cells. Therefore, in this study we evaluated the role <strong>of</strong> IL-6 in the<br />
impairment <strong>of</strong> Treg during the intestinal inflammation induced by T. gondii.<br />
Methods <strong>and</strong> Results: Susceptible C57BL/6 <strong>and</strong> resistant BALB/c mice were<br />
orally infected with 40 cists <strong>of</strong> T. gondii. Eight days post infection we detected a<br />
significant reduction on CD3+CD4+ Foxp3+ Treg cells in the Lamina Propria,<br />
Peyers Patches <strong>and</strong> spleens <strong>of</strong> C57BL/6 mice as compared to BALB/c mice.<br />
The infection compromised mainly the population <strong>of</strong> induced Treg cells, since<br />
the ratio <strong>of</strong> induced/natural Tregs (determined by Helios expression) was also<br />
reduced in mesenteric Lymph nodes (LNM) <strong>and</strong> spleens <strong>of</strong> C57BL/6 mice,<br />
which also exhibited an increased IL-6 production compared to BALB/c. The<br />
protective role <strong>of</strong> Tregs were shown by depleting Tregs from resistant mice with<br />
anti-CD25 antibody (PC61). The anti-CD25 treated BALB/c mice became<br />
susceptible to the infection, presented a higher effector/Treg ratio, <strong>and</strong><br />
produced a larger amounts <strong>of</strong> IFN- <strong>and</strong> IL-6 than non-treated mice. Since<br />
C57BL/6 infected mice produced higher levels <strong>of</strong> IL-6 than infected BALB/c<br />
mice, we supposed that this cytokine could be involved in the Treg impairment<br />
during the infection. To evaluate this, spleen cells were infected in vitro with T.<br />
gondii <strong>and</strong> treated with recombinant IL- 6. The in vitro infection reduced the<br />
frequency <strong>of</strong> Tregs <strong>and</strong> the addition <strong>of</strong> IL-6 to the cultures accentuated even<br />
more the impairment <strong>of</strong> Tregs. Indeed we found that IL-6-/- mice were resistant<br />
to the infection <strong>and</strong> presented higher Treg frequency <strong>and</strong> IFN- production in<br />
the LNM <strong>and</strong> spleens. After the anti-CD25 treatment IL-6-/- mice became